跳至主要内容
临床试验/CTRI/2025/04/084872
CTRI/2025/04/084872尚未招募Phase 3 4

Single arm clinical trial to assess the efficacy of Shunthi Gairik Lepa in Anjananamika w.s.r. To Stye.

No1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2025年4月27日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
35
试验地点
1
主要终点
To determine the efficacy of Shunthi-Gairik Lepa in Anjananamika w.s.r. Stye.

研究概览

简要总结

It is a single arm clinical trial to evaluate the efficacy of Shunthi Gairik Lepa in the management of Anjananamika w.s.t. Stye in the age group of 18 to 60 years of males and females

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 1. Age From 18 year to 60 year 2. Both Male and Female Gender 3. Sign And Symptoms of Anjananamika in Apakva Avastha like Vartmashotha, Vedana, Araktata, kandu, Daha 4. sign and symptom of stye like localised, firm, red, tender swelling at eyelid margin, edema at eyelid margin. 至 60.00 Year(s)(—)

入选标准

  • Age From 18 year to 60 year
  • Both Male and Female Gender
  • Sign And Symptoms of Anjananamika in Apakva Avastha like Vartmashotha, Vedana, Araktata, kandu, Daha
  • sign and symptom of stye like localised, firm, red, tender swelling at eyelid margin, edema at eyelid margin.

排除标准

  • Utsangi pitika, pakva, panchaman Avastha.
  • Pregnant & lactating mothers.
  • K/C/O DM, HTN, TB, anemia, any systemic illness and malignancy.
  • Known cases of congenital disorders of eyelid like Congenital ptosis, congenital coloboma, Epicanthus, Distichiasis, Cryptophthalmos, Microblepharon, Epiblepharon, Euryblepharon.

结局指标

主要结局

To determine the efficacy of Shunthi-Gairik Lepa in Anjananamika w.s.r. Stye.

时间窗: 5 days

次要结局

  • To review concept of Anjananamika(5 days)

研究者

发起方
No
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Saurabh Ishwar Bhandari

SST Ayurved College

研究点 (1)

Loading locations...

相似试验

A study to see the effect of Shunthi Gairik Lepa in... | 临床试验